Nuclear chromatin patterns in 3 glucocorticoid-resistant RPMI 8226 human myeloma cell sub-lines: correlations with cell growth and immunological phenotype

Cancer Biol Ther. 2005 Aug;4(8):832-9. doi: 10.4161/cbt.4.8.1890.

Abstract

Nuclear morphological alterations associated with glucocorticoid resistance in human myeloma were evaluated by image cytometry in three human myeloma RPMI 8226 cell sub-lines. Resistance was induced by drug selection using prednisone (8226p), methylprednisolone (8226m) and dexamethasone (8226d), respectively. All these three cell sub lines displayed significant glucocorticoid-resistance without cross-resistance to doxorubicin. Nuclear geometry and texture were analyzed on G0/G1-selected cell nuclei and data compared with cell growth characteristics and membrane expression of CD23, CD38, CD44 and CD58 antigens. When compared to the parental RPMI 8226 cell line, glucocorticoid-resistant cells display a progressive chromatin condensation with heterogeneously distributed large chromatin clumps, a phenomenon not observed in the multidrug-resistant CEM-VLB cells. These alterations were correlated to the resistance index against glucocorticoids and to the expressions of CD38, and of CD44 variant forms CD44v5 and CD44v7-8 antigens. These data suggest that glucocorticoid resistance in RPMI 8226 cells could be associated with sub-visual specific higher-order chromatin organization changes. Furthermore, these alterations are correlated to the expression of membrane markers associated with tumors aggressiveness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / analysis
  • Antineoplastic Agents, Hormonal* / pharmacology
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Nucleus / ultrastructure*
  • Chromatin / metabolism
  • Chromatin / ultrastructure*
  • Dexamethasone / pharmacology
  • Doxorubicin / pharmacology
  • Drug Resistance, Neoplasm*
  • Flow Cytometry
  • Glucocorticoids* / pharmacology
  • Humans
  • Hyaluronan Receptors / analysis
  • Methylprednisolone / pharmacology
  • Multiple Myeloma / immunology
  • Multiple Myeloma / ultrastructure*
  • Phenotype
  • Prednisone / pharmacology

Substances

  • Antineoplastic Agents, Hormonal
  • Chromatin
  • Glucocorticoids
  • Hyaluronan Receptors
  • Dexamethasone
  • Doxorubicin
  • ADP-ribosyl Cyclase 1
  • Prednisone
  • Methylprednisolone